Yeung, Y., Lau, D. K., Chionh, F., Tran, H., Tse, J. W. T., Weickhardt, A. J., . . . Mariadason, J. M. (2017). K‐Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell lines. Mol Oncol.
Citación estilo ChicagoYeung, Yvonne, et al. "K‐Ras Mutation and Amplification Status Is Predictive of Resistance and High Basal PAKT Is Predictive of Sensitivity to Everolimus in Biliary Tract Cancer Cell Lines." Mol Oncol 2017.
Cita MLAYeung, Yvonne, et al. "K‐Ras Mutation and Amplification Status Is Predictive of Resistance and High Basal PAKT Is Predictive of Sensitivity to Everolimus in Biliary Tract Cancer Cell Lines." Mol Oncol 2017.
Precaución: Estas citas no son 100% exactas.